The "Nasal Drug Delivery Technology - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Representing the developed world, the United States will maintain a 7.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.1 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.2 Billion worth of projected demand in the region will come from the rest of the European markets. In Japan, Nasal Sprays will reach a market size of US$3.2 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 5.9% over the next couple of years and add approximately US$4.4 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

• 3M Company
• Aegis Therapeutics LLC
• Aptargroup, Inc.
• AstraZeneca PLC
• GlaxoSmithKline PLC
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis International AG
• Pfizer, Inc.
  

For more information about this report visit https://www.researchandmarkets.com/r/jwdkpp